The average selling price for VALSALVA in Belgium grew in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the VALSALVA device in Belgium can be viewed in GlobalData’s micro pricing report. Buy the report here.
Go deeper with GlobalData
The VALSALVA is sold by Livanova Plc in the Tissue Sutured Aortic Valve Replacements market. Tissue sutured aortic valve replacements are used for replacement of the aortic heart valve using a biological prosthesis. They are made from a stented tissue valve that can be compressed to become smaller. The valve does not require sutures to stay in place.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Livanova Plc’ Tissue Sutured Aortic Valve Replacements device pricing in Belgium, buy the report here.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
